Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Schiff

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
Nature Communications|June 7, 2022
Neonatal gene therapy achieves sustained disease rescue of maple syrup urine disease in miceClément Pontoizeau, Marcelo Simon-Sola, Clovis Gaborit, et al.
Molecular Genetics and Metabolism|February 7, 2025
Bone mineral density in French adults with early-treated phenylketonuriaElisa Dybal, François Maillot, François Feillet, et al.
Orphanet Journal of Rare Diseases|May 16, 2022
Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational studyJean-Meidi Alili, Marie-Pierre Berleur, Marie-Caroline Husson, et al.
Journal of Neurology|December 12, 2024
Neuropsychological profile of French adults with early-treated phenylketonuria: a multicenter studyMaxime Brachet, Sybil Charrière, Claire Douillard, et al.
Journal of Inherited Metabolic Disease|October 24, 2020
Long term outcome of MPI-CDG patients on D-mannose therapyMuriel Girard, Claire Douillard, Dominique Debray, et al.
Mitochondrion|February 20, 2026
From variant interpretation to structural discovery: A new Zinc-binding domain in PARS2Célia Hoebeke, Camille Engel, Claire-Marine Berat, et al.
Molecular Genetics and Metabolism|February 27, 2018
Fluxomic assay-assisted diagnosis orientation in a cohort of 11 patients with myopathic form of CPT2 deficiencyMonique Fontaine, Isabelle Kim, Anne-Frédérique Dessein, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|March 23, 2024
Vitamin deficiencies in children: Lessons from clinical and neuroimaging findingsGabrielle Dupuy, Charles-Joris Roux, Rémi Barrois, et al.
Molecular Genetics and Metabolism|June 18, 2021
Should patients with Phosphomannomutase 2-CDG (PMM2-CDG) be screened for adrenal insufficiency?Anna Čechová, Tomáš Honzík, Andrew C Edmondson, et al.
Frontiers in Genetics|February 13, 2024
Recurrent "outsider" intronic variation in the <i>SLC5A</i>6 gene causes severe mixed axonal and demyelinating neuropathy, cyclic vomiting and optic atrophy in 3 families from MaghrebLamisse Mansour-Hendili, Cyril Gitiaux, Madeleine Harion, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
Nature Communications|June 7, 2022
Neonatal gene therapy achieves sustained disease rescue of maple syrup urine disease in miceClément Pontoizeau, Marcelo Simon-Sola, Clovis Gaborit, et al.
Molecular Genetics and Metabolism|February 7, 2025
Bone mineral density in French adults with early-treated phenylketonuriaElisa Dybal, François Maillot, François Feillet, et al.
Orphanet Journal of Rare Diseases|May 16, 2022
Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational studyJean-Meidi Alili, Marie-Pierre Berleur, Marie-Caroline Husson, et al.
Journal of Neurology|December 12, 2024
Neuropsychological profile of French adults with early-treated phenylketonuria: a multicenter studyMaxime Brachet, Sybil Charrière, Claire Douillard, et al.
Journal of Inherited Metabolic Disease|October 24, 2020
Long term outcome of MPI-CDG patients on D-mannose therapyMuriel Girard, Claire Douillard, Dominique Debray, et al.
Mitochondrion|February 20, 2026
From variant interpretation to structural discovery: A new Zinc-binding domain in PARS2Célia Hoebeke, Camille Engel, Claire-Marine Berat, et al.
Molecular Genetics and Metabolism|February 27, 2018
Fluxomic assay-assisted diagnosis orientation in a cohort of 11 patients with myopathic form of CPT2 deficiencyMonique Fontaine, Isabelle Kim, Anne-Frédérique Dessein, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|March 23, 2024
Vitamin deficiencies in children: Lessons from clinical and neuroimaging findingsGabrielle Dupuy, Charles-Joris Roux, Rémi Barrois, et al.
Molecular Genetics and Metabolism|June 18, 2021
Should patients with Phosphomannomutase 2-CDG (PMM2-CDG) be screened for adrenal insufficiency?Anna Čechová, Tomáš Honzík, Andrew C Edmondson, et al.
Frontiers in Genetics|February 13, 2024
Recurrent "outsider" intronic variation in the <i>SLC5A</i>6 gene causes severe mixed axonal and demyelinating neuropathy, cyclic vomiting and optic atrophy in 3 families from MaghrebLamisse Mansour-Hendili, Cyril Gitiaux, Madeleine Harion, et al.
Pageof 16